1 April 2012Patents

GSK announces £500m UK investment after patent box confirmed

Pharmaceutical maker GlaxoSmithKline (GSK) is to invest more than £500 million in UK manufacturing following the chancellor’s announcement of tax relief for UK and European patent profits.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

Too busy to save time? Why IP teams can’t afford to wait on AI

Weil continues IP expansion as another litigator jumps from rival firm

WIPR Rankings reveals the go-to firms and attorneys for China patent work

Fed Circ won’t bite on first IPR-policy challenges

New AIPLA president calls for greater certainty in US patent law

Squires plays rare reexamination of Pokémon gaming patent

WATCH: AI for patent drafting & prosecution—reshaping IP workflows

AI is an upstart teen: Meta, Adobe counsel on where the tech is at

GSK announces £500m UK investment after patent box confirmed

Editor's picks

Editor's picks

More articles